A novel non-embyronic stem cell therapy is being studied to replace damaged dopaminergic brain cells in Parkinson's patients with their own cells in the hopes of restoring normal movement.

The Parkinson's Association of San Diego, Scripps Research Institute and Scripps Clinic have mounted an effort to promote the treatment, which is based on the harvesting of stem cells from patients' skin. A formal application for the treatment will reportedly be filed with the FDA this month.